INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
LR
Lerner Lorena RaquelChief Science Officer
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$63K
3,873 sh
Feb 18, 2026
Page 1268 of 1786
← PrevNext →
Feb 20, 2026
traded Feb 18, 2026
+2d
SEC Form 4

Evidence

33
CE
Cho EstherSVP, General Counsel
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$78K
4,745 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

31
TJ
Tasker Anthony JamesSVP & COO
FUNCFIRST UNITED CORP/MD/
Open-market sale
SELL$33.11
1 sh
Feb 4, 2026Feb 20, 2026
traded Feb 4, 2026
+16dSEC Form 4

Evidence

30
DD
Day DonaldEVP - SITE LEASING
SBACSBA COMMUNICATIONS CORP
Option exercise
M$1.05M
5,739 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

30
DD
Day DonaldEVP - SITE LEASING
SBACSBA COMMUNICATIONS CORP
Tax withholding
F$1.09M
5,367 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

29
CG
Casella Matthew G.Former officer
RRRICHTECH ROBOTICS INC.
Open-market sale
SELL$34K
12.5K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
CG
Campbell Darrell GeorgeEVP - CFO
SNDRSchneider National, Inc.
Open-market sale
SELL$173K
6,000 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Open-market sale
SELL$127K
1,197 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
GS
Griffis SarahChief Technology Officer
MAPSWM TECHNOLOGY, INC.
Open-market sale
SELL$183K
271.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

26
PE
Phelps ErikEVP, Chief Admin. Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$334K
5,650 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

25
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$65K
10.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

24
HA
Hlila Alexandra M AEVP & GM - GLOBAL PEST
ECLECOLAB INC.
Tax withholding
F$65K
215 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$654K
10.8K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

23
GN
Gabay Michael NissimEVP
BCOBRINKS CO
Grant or award
A$445K
3,426 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$481K
8,143 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
SM
Schafer Douglas M. JREVP and CIO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$1.33M
32.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$58K
711 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$19K
3,016 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$56K
698 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

21
CR
Cavorsi RobertVice President, Strategy
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
93.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
HA
Hlila Alexandra M AEVP & GM - GLOBAL PEST
ECLECOLAB INC.
Grant or award
A—
508 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Open-market sale
SELL$27K
5,290 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
RJ
Rinke Todd J.Senior Vice President
WMBWILLIAMS COMPANIES, INC.
Grant or award
A—
2,467 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
GL
Glassberg Brian LEVP, General Counsel & Secy.
GATXGATX CORP
Grant or award
A—
2,790 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
SM
Sanchez MariolaSee remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
1,740 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
EJ
Eelman Anthony J.EVP, Chief Products Officer
AMTBAmerant Bancorp Inc.
Option exercise
M—
333 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
LG
Lustig GarrettDirector
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
SC
Siatis Perry CEVP, GC AND SECRETARY
ABBVAbbVie Inc.
Grant or award
A—
16.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
GP
Georgakopoulos PanagiotisCo-President
FISVFISERV INC
Grant or award
A—
182.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
WA
Williams Karen AChief Financial Officer
GBTGGlobal Business Travel Group, Inc.
Grant or award
A—
246.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
CS
Calderon SharymarSEVP - Chief Financial Officer
AMTBAmerant Bancorp Inc.
Option exercise
M—
2,490 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
MJ
Miller Curtis JohnChief Strategy Officer
NIQNIQ Global Intelligence plc
Grant or award
A—
39.5K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
NE
Nursey Michael E.See remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
666 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
PP
Parra PedroSee Remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
666 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
RA
Rodriguez AdrianSee remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
833 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
BM
Boone Jandeen MEVP, GC & Secretary
ECLECOLAB INC.
Grant or award
A—
593 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
PR
Purdue David RyanSVP, Controller
ABBVAbbVie Inc.
Grant or award
A—
2,505 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
NE
Nursey Michael E.See remarks
AMTBAmerant Bancorp Inc.
Option exercise
M—
666 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

20
GL
Glassberg Brian LEVP, General Counsel & Secy.
GATXGATX CORP
Tax withholding
F$238K
1,236 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

20
BM
Boone Jandeen MEVP, GC & Secretary
ECLECOLAB INC.
Tax withholding
F$61K
201 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence